CV Sciences, Inc. (OTCMKTS:CVSI) Sees Significant Growth in Short Interest

CV Sciences, Inc. (OTCMKTS:CVSI) saw a significant increase in short interest in December. As of December 15th, there was short interest totalling 36,600 shares, an increase of 363.3% from the November 30th total of 7,900 shares. Based on an average trading volume of 614,900 shares, the short-interest ratio is currently 0.1 days.

CV Sciences Stock Performance

Shares of CV Sciences stock traded up $0.00 on Friday, hitting $0.04. The company had a trading volume of 34,990 shares, compared to its average volume of 281,960. CV Sciences has a 1 year low of $0.03 and a 1 year high of $0.10. The stock has a 50 day moving average of $0.04 and a 200-day moving average of $0.05. The stock has a market capitalization of $6.60 million, a price-to-earnings ratio of -3.57 and a beta of 0.62.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.